Abivax closes down 9% following short report


Red Arrow Moving Down Over Graph Paper Background

MicroStockHub

Abivax (ABVX) closed Friday down ~9% following a short report from Scorpion Research, which attacked the clinical development of the company’s ulcerative colitis candidate obefazimod.

Scorpion revealed it has a short position in Abivax. The firm claims that the asset exhibits “



Source link

LG’s largest OLED TV is getting a major upgrade in 2027

Bowen Yang Apologizes for Calling Regina Spektor an Antisemitic Slur

Leave a Reply

Your email address will not be published. Required fields are marked *